Table 2 Comparison of preoperative baseline, biochemical and cardiac function indexes between the two groups
From: Effect of the COVID-19 pandemic on complications and mortality of patients with cardiac surgery
Characteristics | Control group (n = 292) | Observation group (n = 130) | P-value |
|---|---|---|---|
Age, years | 55 (44–62) | 54 (47–61) | 0.935 |
Countryside (%) | 187 (64.04) | 82 (63.08) | 0.849 |
Men (%)c | 184 (63.01) | 89 (68.46) | 0.280 |
Shaanxi Province (%) | 182 (62.33) | 105 (81.77) | 0.000 |
Smoking (%) | 100 (34.25) | 58 (44.62) | 0.042 |
Alcoholism (%) | 16 (5.48) | 19 (14.62) | 0.002 |
Distance (km) | 132 (35.5–237) | 142 (42.25–237.5) | 0.778 |
Family company (%) | 223 (76.37) | 84 (64.62) | 0.012 |
BMI (kg/m2) | 23.15 (20.43–25.70) | 24.14 (21.25–25.95) | 0.130 |
History of hypertension (%) | 77 (26.37) | 43 (33.08) | 0.159 |
History of diabetes (%) | 32 (10.96) | 10 (7.69) | 0.301 |
History of COPD (%) | 9 (3.08) | 3 (2.31) | 0.659 |
History of hyperlipidemia (%) | 40 (13.70) | 27 (20.77) | 0.067 |
PAH (%) | 59 (20.21) | 18 (13.85) | 0.118 |
Arteriography (%) | 118 (40.41) | 79 (60.77) | 0.000 |
EuroSCORE (score) | 2 (0–5) | 6.5 (2–9) | 0.000 |
Emergency admission (%) | 62 (21.23) | 65 (50.00) | 0.000 |
Severe patients (%) | 80 (27.40) | 71 (54.62) | 0.000 |
Disease time, years | 3.96 ± 10.19 | 2.54 ± 6.25 | 0.144 |
HGB (g/L) | 132 (122–142) | 134 (121–143) | 0.881 |
Eosinophil count (109/L) | 0.07 (0.04–0.14) | 0.06 (0.02–0.14) | 0.323 |
Leucocyte count (109/L) | 6.14 (4.86–8.08) | 6.59 (4.95–9.62) | 0.029 |
Lymphocyte count (109/L) | 1.48 (1.04–1.97) | 1.33 (0.96–1.72) | 0.057 |
ALB (g/L) | 40.50 (37.50–43.88) | 37.15 (34.83–40.03) | 0.000 |
Globulin (U/ml) | 24.50 (21.03–27.90) | 25.10 (22.08–27.93) | 0.216 |
Partial pressure of oxygen (mmHg) | 85.15 (74.60–93.55) | 80.30 (71.15–89.38) | 0.007 |
Pro-BNP (ng/L) | 542.40 (113.45–1776.75) | 857.50 (241.00–2222.50) | 0.018 |
LVEF (%) | 59 (50–64) | 59 (51–63) | 0.828 |